Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Berezhnoy, Dmytro, Gravielle, Maria C, Downing, Scott, Kostakis, Emmanuel, Basile, Anthony S, Skolnick, Phil, Gibbs, Terrell T, Farb, David H
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2008
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2529273/
https://ncbi.nlm.nih.gov/pubmed/18554397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-8-11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares